Cassiana Regina de Góes
Barbara Perez Vogt
Annabel Biruete
Thomas J. Wilkinson4
Matthew Snelson- 1Federal University of Viçosa, Rio Paranaiba Campus, Rio Paranaiba, Brazil
- 2Graduate Program in Health Sciences, Medicine Faculty, Federal University of Uberlandia, Uberlândia, Brazil
- 3Department of Nutrition Science, Purdue University, West Lafayette, IN, United States
- 4Leicester Diabetes Centre, University of Leicester, Leicester, United Kingdom
- 5Department of Diabetes, Monash University, Melbourne, VIC, Australia
Editorial on the Research Topic
Nutrition and metabolism in kidney diseases
Introduction
The impairment of kidney function, which occurs in chronic kidney disease (CKD) and acute kidney injury (AKI), promotes specific alterations in nutrient metabolism (1) and induces a pro-inflammatory state (2). These alterations affect the nutritional status of the patients and increase morbidity and mortality risk. Among the many factors that are associated with poor outcomes in this population, protein-energy wasting, malnutrition, and sarcopenia play a significant role.
Nutritional management in individuals with impaired kidney function varies depending on the disease severity, nutritional status, cause of disease, comorbidities, medications, and treatment methods. Therefore, understanding the available methods for assessing nutritional status, establishing dietary requirements, and strategies for preventing or treating potential nutritional derangements is essential for optimal care of patients with kidney diseases. This Research Topic focuses on recent studies exploring nutrition and metabolism in CKD.
Energy requirements and CKD
In individuals with CKD, energy requirements have traditionally been considered to be higher based on early nitrogen balance studies. However, more recent studies have questioned these higher recommendations (3–5). Indirect calorimetry is the gold standard for measuring resting energy expenditure (REE); however, its availability in clinical settings is limited. Ramos-Acevedo et al., performed a study in individuals with CKD stages 3–5 without kidney replacement therapy, incorporating measures of nutritional status and other clinical variables. They found good concordance between their models and others validated in CKD. The authors concluded that clinicians should consider using formulas that include nutritional status and other variables, such as weight, fat-free mass, comorbidities, sex, and age, to estimate energy requirements.
Similarly, Abi et al. utilized indirect calorimetry to measure REE in patients with stage 3–5 CKD and assess the relationship with the adipokines leptin, IL-6 and adiponectin in serum. In an initial analysis, the authors found that REE was positively correlated with leptin in males and females and negatively correlated with adiponectin in males only. However, when fat mass was accounted for using a multivariate linear regression model, the only significant relationship observed was between REE and leptin in males. This study highlights the importance of considering the degree of adiposity when studying adipokines, as well as the possibility of a sex-specific relationship between adipokines and energy expenditure in CKD patients.
Plasma biomarkers in CKD
Cardiovascular mortality is increased in populations with CKD, and there is considerable interest in how commonly assessed lipid risk factors can be utilized to understand and modulate cardiovascular risk (6). In a large retrospective study of Chinese peritoneal dialysis (PD) patients, Wu et al. observed that there was a U-shaped relationship between LDL cholesterol levels and cardiovascular mortality. When a subgroup analysis was performed, this U-shaped relationship only remained significant in those with serum albumin of <36 g/L, used as a biomarker of malnutrition. The authors concluded that nutritional status modifies the relationship between LDL cholesterol and cardiovascular mortality in PD.
Lecamwasam et al. compared clinical and metabolomic data between patients with diabetes and early or late-stage CKD. In this study, the authors found no difference in LDL cholesterol between groups, although low-density lipoprotein triglyceride (LDL-TG) was increased in the late CKD group. The ratio between Apolipoprotein B1 and Apolipoprotein A1 (ApoB/ApoA1), a well-established risk factor for cardiovascular disease (7), was increased in the late CKD group, driven by a reduction in ApoA1. These findings suggest that apolipoproteins may be useful for assessing cardiovascular risk in high risk populations such as CKD patients.
Trimethylamine N-oxide (TMAO) is a uremic toxin which has been implicated in cardiovascular disease (8). Murray et al. fed pigs a highly heat-treated diet, high in resistant protein and found a profound alteration in the composition of the gut microbiota and changes in the plasma metabolome. They found that the resistant protein diet increased plasma TMAO and reduced plasma acetate, a beneficial short-chain fatty acid that is produced predominantly by the gut microbiota. This provides emerging evidence for the role of dietary resistant protein modulating the gut microbiota in the pathogenesis of cardiovascular disease in CKD.
Adverse body composition in CKD and interventions to improve it
Sarcopenia is highly prevalent in patients living with CKD (9), yet a reliable and simple means to assess it is lacking. The product of serum creatinine and the estimated glomerular filtration rate based on cystatin C was recently proposed as a sarcopenia index. Lin et al. evaluated the sarcopenia index in 297 patients with non-dialysis stage 3b-5 CKD. They found the sarcopenia index had acceptable discriminative ability to detect sarcopenia. As such, sarcopenia index could be used as a surrogate marker for sarcopenia and may be helpful for screening in advanced CKD.
Aside from measuring body composition, bioelectrical impedance analysis also provides the phase angle, a composite marker influenced by hydration and integrity of the body cell membrane (10). Reis et al. evaluated whether the phase angle could be used as a nutritional marker and predictor of mortality in PD patients. Their findings revealed an inverse correlation between the phase angle and coronary artery calcium score, a predictor of the incidence of acute myocardial infarction and death from cardiovascular disease.
Oral nutritional supplementation (ONS) is one of the interventions recommended to manage muscle wasting in patients on maintenance hemodialysis if diet alone does not provide sufficient energy and protein intake (11). In a randomized controlled trial of 56 patients with protein energy wasting, Sahathevan et al. showed improvement in muscle mass parameters assessed by ultrasound after a 6-month ONS compared to nutritional counseling. In a small open randomized pilot trial, González-Ortiz et al. showed both intradialytic or at home ONS improved not only nutritional parameters, such as body mass index and normalized protein nitrogen appearance, as well as sleep quality in 23 patients on maintenance hemodialysis.
Obesity is also a critical issue in the CKD population. Post-transplant increases in fat mass are usually associated with insulin resistance and cardiovascular risk factors in kidney transplant recipients (12). Another intervention approached in this Research Topic was a personalized digital health intervention, with the aim to prevent weight gain after kidney transplantation. Castle et al. showed this intervention was feasible and acceptable for recent kidney transplant recipients.
Malnutrition and diet management
Malnutrition may also be associated with kidney-related outcomes, such as increased susceptibility to AKI (13, 14). A study by Liang et al. observed that elderly patients with malnutrition, assessed by the Controlling Nutritional Status score (CONUT score), who underwent percutaneous coronary intervention, had a 2-fold increased adjusted risk of contrast-associated AKI, compared to those with no malnutrition.
Zinc is an essential micronutrient involved in numerous metabolic processes. AKI is associated with low plasma zinc (15), but outcomes with zinc supplementation in critically ill patients with AKI remain limited. Xia et al. investigated the effectiveness of zinc supplementation in 9811 patients with AKI. They found zinc supplementation was associated with improved survival in critically ill patients with AKI. Whilst further study is needed, this study highlights potential benefits of zinc supplementation in critically ill patients with AKI.
Diet management plays a crucial role in treating potential or ongoing nutritional deficiencies and derangements in patients undergoing hemodialysis (11). However, current dietary recommendations may not be culturally appropriate. In a qualitative study, Song et al. conducted semi-structured interviews with 23 patients in China on hemodialysis to explore their perceptions and attitudes toward diet. Findings showed diet behavior in Chinese patients undergoing hemodialysis is strongly influenced by culture. Culturally sensitive interventions regarding the improvement of diet intake are urgently needed.
Healthy lifestyle behaviors, including a healthy diet, weight control and physical activity promote the kidney health of children, reducing long-term kidney damage in adulthood (16). Physical activity may have an impact on hydration status and kidney health, but the interaction of hydration status and physical activity level on kidney function is not well-studied in children. Li et al. explored associations of kidney damage with the interaction of hydration status and physical activity level in 1,914 primary school children from China. They found longitudinal interactions of hydration status and physical activity level on early kidney damage and found increased dehydration among the children over time. These results support the importance of adequate water intake, and suggest that children can be protected from early kidney damage by euhydration, either with sufficient or insufficient physical activity.
Perspectives
In summary, the studies included in the Research Topic on “Nutrition and metabolism in kidney diseases” enrich our understanding on a wide variety of topics, from nutritional assessment aspects, such as energy expenditure, body composition, bioelectrical impedance analysis parameters, and new and traditional biomarkers evaluation, to nutritional management of the main nutritional disorders in CKD and AKI, including malnutrition, sarcopenia, macro And micronutrients deficiency, and obesity. The articles included in this collection highlight future research directions, assist in the development of novel therapeutic approaches, and contribute to improvements in clinical practice.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
TW was supported by the NIHR Applied Research Collaboration East Midlands. AB was funded by an Indiana-CTSI KL2 [with support from Grant Numbers: KL2TR002530 (Sheri Robb, PI) and UL1TR002529 (Sarah Wiehe and Sharon Moe, co-PIs) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award].
Acknowledgments
We thank all the authors and reviewers who have participated in this Research Topic.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Fiaccadori E, Sabatino A, Barazzoni R, Carrero JJ, Cupisti A, De Waele E, et al. ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease. Clin Nutr. (2021) 40:1644–68. doi: 10.1016/j.clnu.2021.01.028
2. Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis. (1998) 32:834–41. doi: 10.1016/S0272-6386(98)70148-9
3. Xu X, Yang Z, Ma T, Li Z, Chen Y, Zheng Y, et al. Novel equation for estimating resting energy expenditure in patients with chronic kidney disease. Am J Clin Nutr. (2021) 113:1647–56. doi: 10.1093/ajcn/nqaa431
4. Avesani CM, Draibe SA, Kamimura MA, Dalboni MA, Colugnati FAB, Cuppari L. Decreased resting energy expenditure in non-dialysed chronic kidney disease patients. Nephrol Dial Transplant. (2004) 19:3091–7. doi: 10.1093/ndt/gfh547
5. D'Alessandro C, Giannese D, Avino M, Cupisti A. Energy requirement for elderly CKD patients. Nutrients. (2021) 13:3396. doi: 10.3390/nu13103396
6. Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease. Circulation. (2021) 143:1157–72. doi: 10.1161/CIRCULATIONAHA.120.050686
7. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. (2008) 372:224–33. doi: 10.1016/S0140-6736(08)61076-4
8. Snelson M, Biruete A, McFarlane C, Campbell K. A renal clinician's guide to the gut microbiota. J Ren Nutr. (2020) 30:384–95. doi: 10.1053/j.jrn.2019.11.002
9. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. (2021) 34:1347–72. doi: 10.1007/s40620-020-00840-y
10. Norman K, Stobäus N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis – clinical relevance and applicability of impedance parameters. Clin Nutr. (2012) 31:854–61. doi: 10.1016/j.clnu.2012.05.008
11. Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. (2020) 76(3, Suppl. 1):S1–107. doi: 10.1053/j.ajkd.2020.05.006
12. Chan W, Bosch JA, Jones D, McTernan PG, Phillips AC, Borrows R. Obesity in kidney transplantation. J Ren Nutr. (2014) 24:1–12. doi: 10.1053/j.jrn.2013.09.002
13. Li P, Li C, Mishra AK, Cai P, Lu X, Sherif AA, et al. Impact of malnutrition on in-hospital outcomes in takotsubo cardiomyopathy. Nutrition. (2022) 93:111495. doi: 10.1016/j.nut.2021.111495
14. Wang N, Wang P, Li W, Jiang L, Wang M, Zhu B, et al. Prognostic significance of malnutrition risk in elderly patients with acute kidney injury in the intensive care unit. BMC Nephrol. (2022) 23:335. doi: 10.1186/s12882-022-02949-7
15. Ostermann M, Summers J, Lei K, Card D, Harrington DJ, Sherwood R, et al. Micronutrients in critically ill patients with severe acute kidney injury – a prospective study. Sci Rep. (2020) 10:1505. doi: 10.1038/s41598-020-58115-2
Keywords: acute kidney injury, body composition, chronic kidney disease, kidney replacement therapy, physical exercise, sarcopenia, protein-energy wasting (PEW)
Citation: de Góes CR, Vogt BP, Biruete A, Wilkinson TJ and Snelson M (2023) Editorial: Nutrition and metabolism in kidney diseases. Front. Nutr. 10:1088977. doi: 10.3389/fnut.2023.1088977
Received: 03 November 2022; Accepted: 23 January 2023;
Published: 03 February 2023.
Edited by:
Giuseppe Regolisti, University of Parma, ItalyReviewed by:
Jeroen Peter Kooman, Maastricht University Medical Centre, NetherlandsAdamasco Cupisti, University of Pisa, Italy
Copyright © 2023 de Góes, Vogt, Biruete, Wilkinson and Snelson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cassiana Regina de Góes, 
Y2Fzc2lhbmEuZ29lcyYjeDAwMDQwO3lhaG9vLmNvbS5icg==